来源:[1] Galafold能否推动Amicus在2025年剩余时间里的增长? (https://finance.yahoo.com/news/galafold-drive ...)[2] Amicus Therapeutics (FOLD):通过战略交易和管线势头确保罕见病主导地位 - AInvest (https://ainvest.com/news/amicus-therapeutics- ...)[3] Galafold能否推动Amicus在2025年剩余时间里的增长? - Nasdaq (https://vertexaisearch.cloud.google.com/groun ...)